Medi-Caps Informe acción BSE:523144 Capitalización de mercado
₹641.0m
Medi-Caps Limited
Informe acción BSE:523144
Capitalización de mercado: ₹641.0m
Resumen de acción 523144 Medi-Caps Limited se dedica al negocio inmobiliario en la India.
Recompensas Análisis de riesgos Ver todos los controles de riesgos Competidores de Medi-Caps Limited Historial de precios y rendimiento
Resumen de todos los máximos históricos, cambios y caídas de precios de Medi-Caps Precios históricos de las acciones Precio actual de la acción ₹51.40 Máximo en las últimas 52 semanas ₹63.49 Mínimo de 52 semanas ₹40.56 Beta 0.68 1Cambio en 1 mes 4.03% Variación en 3 meses 7.26% Cambio de 1 año 1.48% 3Variación en 3 años 22.67% Variación en 5 años 323.05% Variación desde la OPV 13,606.67%
Noticias y actualizaciones recientes
Medi-Caps Limited to Report Q2, 2025 Results on Nov 12, 2024 Nov 09
First quarter 2025 earnings released: ₹0.45 loss per share (vs ₹0.89 loss in 1Q 2024) Aug 08
Medi-Caps Limited, Annual General Meeting, Sep 26, 2024 Aug 07
Medi-Caps Limited to Report Q1, 2025 Results on Aug 07, 2024 Aug 02
Medi-Caps Limited Announces Retirement of Mr. Pramod Fatehpuria as Independent Director May 30
Full year 2024 earnings released: ₹1.80 loss per share (vs ₹1.50 profit in FY 2023) May 25 Ver más actualizaciones
Medi-Caps Limited to Report Q2, 2025 Results on Nov 12, 2024 Nov 09
First quarter 2025 earnings released: ₹0.45 loss per share (vs ₹0.89 loss in 1Q 2024) Aug 08
Medi-Caps Limited, Annual General Meeting, Sep 26, 2024 Aug 07
Medi-Caps Limited to Report Q1, 2025 Results on Aug 07, 2024 Aug 02
Medi-Caps Limited Announces Retirement of Mr. Pramod Fatehpuria as Independent Director May 30
Full year 2024 earnings released: ₹1.80 loss per share (vs ₹1.50 profit in FY 2023) May 25
Medi-Caps Limited to Report Q4, 2024 Results on May 23, 2024 May 17
Insufficient new directors Mar 01
Third quarter 2024 earnings released: ₹0.13 loss per share (vs ₹1.04 loss in 3Q 2023) Feb 09
Second quarter 2024 earnings released: EPS: ₹0.09 (vs ₹1.74 in 2Q 2023) Nov 14
New minor risk - Share price stability Nov 13
Medi-Caps Limited Announces Change in Management Nov 09
Medi-Caps Limited Approves Change in Designation of Gajendra Singh from Additional Director to Non Executive Independent Director Oct 01
Medi-Caps Limited, Annual General Meeting, Sep 29, 2023 Aug 30
Medi-Caps Limited Appoints Gajendra Singh as an Additional Director Aug 12
Medi-Caps Limited to Report Q1, 2024 Results on Aug 11, 2023 Aug 05
Medi-Caps Limited Announces Resignation of Akshit Garg as Non Executive Non Independent Director Jul 14
Full year 2023 earnings released: EPS: ₹1.50 (vs ₹8.05 in FY 2022) May 25
Investor sentiment improves as stock rises 17% Apr 05
Third quarter 2023 earnings released: ₹1.04 loss per share (vs ₹1.67 profit in 3Q 2022) Feb 12
Medi-Caps Limited to Report Q3, 2023 Results on Feb 09, 2023 Feb 02
Medi-Caps Limited to Report Q2, 2023 Results on Nov 10, 2022 Nov 05
Investor sentiment deteriorated over the past week Aug 11
Medi-Caps Limited, Annual General Meeting, Sep 28, 2022 Aug 06
First quarter 2023 earnings released: EPS: ₹0.52 (vs ₹2.63 in 1Q 2022) Aug 05
Medi-Caps Limited to Report Q1, 2023 Results on Aug 04, 2022 Jul 28
Investor sentiment deteriorated over the past week Jun 17
Full year 2022 earnings released: EPS: ₹8.05 (vs ₹9.02 in FY 2021) May 30
Medi-Caps Limited to Report Q4, 2022 Results on May 25, 2022 May 18
Investor sentiment improved over the past week Apr 06
Investor sentiment deteriorated over the past week Feb 22
Investor sentiment deteriorated over the past week Feb 22
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 13
Medi-Caps Limited to Report Q3, 2022 Results on Feb 10, 2022 Feb 03
Second quarter 2022 earnings released: EPS ₹2.59 (vs ₹2.94 in 2Q 2021) Nov 12
Full year 2021 earnings released: EPS ₹11.16 (vs ₹4.69 loss in FY 2020) Jun 29
Investor sentiment improved over the past week May 25
Investor sentiment improved over the past week Mar 06
New 90-day high: ₹35.00 Mar 05
Investor sentiment improved over the past week Feb 12
New 90-day high: ₹29.45 Feb 08
Medi-Caps Limited Appoints Dharmendra Solanki as an Additional as Well as Non Executive Independent Director Feb 06
Third quarter 2021 earnings released: EPS ₹3.54 (vs ₹2.63 loss in 3Q 2020) Feb 06
Medi-Caps Limited to Report Q3, 2021 Results on Feb 05, 2021 Feb 01
New 90-day high: ₹24.65 Dec 09
Medi-Caps Limited Announces Demise of Shamsher Singh, Non-Executive Independent Director Nov 25
New 90-day high: ₹23.95 Nov 12
Medi-Caps Limited to Report Q2, 2021 Results on Nov 06, 2020 Oct 30
New 90-day high - ₹13.18 Jul 28 Rentabilidad de los accionistas 523144 IN Packaging Mercado IN 7D -5.1% -0.3% 0.1% 1Y 1.5% 25.5% 33.4%
Ver rendimientos de los accionistas
Rentabilidad vs. Industria: Los resultados de 523144 fueron inferiores a los de la industria Indian Packaging, que obtuvo un rendimiento del 25.5% el año pasado.
Rentabilidad vs. Mercado: 523144 obtuvo unos resultados inferiores a los del mercado Indian, que fueron del 33.4% el año pasado.
Volatilidad de los precios Is 523144's price volatile compared to industry and market? 523144 volatility 523144 Average Weekly Movement 6.6% Packaging Industry Average Movement 7.3% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.2% 10% least volatile stocks in IN Market 3.9%
Precio estable de las acciones: 523144 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 523144 (7%) se ha mantenido estable durante el año pasado.
Acerca de la empresa Medi-Caps Limited se dedica al negocio inmobiliario en la India. Se centra en el desarrollo de propiedades residenciales y comerciales. La empresa se constituyó en 1983 y tiene su sede en Indore (India).
Mostrar más Resumen de fundamentos de Medi-Caps Limited ¿Cómo se comparan los beneficios e ingresos de Medi-Caps con su capitalización de mercado? Estadísticas fundamentales de 523144 Capitalización bursátil ₹640.96m Beneficios(TTM ) -₹16.83m Ingresos (TTM ) ₹271.63m
2.4x Ratio precio-ventas (PS)
-38.1x Ratio precio-beneficio (PE) Beneficios e Ingresos Estadísticas clave de rentabilidad del último informe de resultados (TTM) Cuenta de resultados (TTM ) de 523144 Ingresos ₹271.63m Coste de los ingresos ₹101.76m Beneficio bruto ₹169.86m Otros gastos ₹186.69m Beneficios -₹16.83m
Últimos beneficios comunicados
Jun 30, 2024
Próxima fecha de beneficios
n/a
Beneficios por acción (BPA) -1.35 Margen bruto 62.54% Margen de beneficio neto -6.20% Ratio deuda/patrimonio 0%
¿Cómo se ha desempeñado 523144 a largo plazo?
Ver rendimiento histórico y comparativa
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
